Pulmonary hypertension (PH) is defined as a mean pulmonary artery pressure (PAP) "25 mmHg at rest as assessed by right heart catheterization (RHC), and Doppler-derived systolic PAP (sPAPECHO) or tricuspid regurgitation pressure gradient (TRPG) is widely used to screen for PH. However, the cutoff value of sPAPECHO or TRPG for detecting a mean PAP "25 mmHg that was determined invasively has not been well defined.
P ulmonary hypertension (PH) is a hemodynamic condition that is defined as elevated mean pulmonary artery pressure (PAP) ("25 mmHg at rest) but not elevated systolic PAP as assessed by right heart catheterization (RHC).
1) The mean PAP reflects the driving pressure that is required for pulmonary blood flow more accurately than systolic PAP, and systolic PAP is more related to stroke volume and systemic arterial pressure than mean PAP. 2, 3) Noninvasive transthoracic Doppler echocardiography (DE) has become widely used for screening patients for PH by estimating systolic PAP. By taking into account the right atrial pressure (RAP) described by the simplified Bernoulli equation, the systolic PAP can be estimated on the basis of the peak tricuspid regurgitation (TR) velocity. 4 ) Although a number of previous studies have reported the accuracy of the DE estimation of systolic PAP compared with that obtained by RHC, [5] [6] [7] [8] [9] [10] [11] [12] recent studies [9] [10] [11] [12] [13] [14] [15] showed that the agreement between the two methods was limited. Therefore, the American College of Cardiology Foundation and the American Heart Association expert consensus document on PH 16) emphasize the importance of the estimated SAP by DE in the screening of PH defined as a mean PAP "25 mmHg rather than in the estimation of systolic PAP. However, to date, only studies with small and limited patient populations have reported the correlation between mean PAP by RHC and systolic PAP by DE, 17) and they did not estimate RAP according to the current guideline from the American Society of Echocardiography (ASE). 4) Therefore, a guideline from the ASE 4) does not propose the best cutoff values of systolic PAP by DE to detect the PH defined as a mean PAP but suggests normal resting values of a peak TR velocity (!2.8-2.9 m/ second) and a peak systolic PAP (35 or 36 mmHg). Recently, Greiner, et al. 18) reported that the noninvasive diagnosis of PH with DE had good sensitivity and specificity by using a systolic PAP cutoff value of 36 mmHg in a large number of patients. However, DE and PH ASSESSED BY THE DE METHOD RHC were performed within 5 days in this study. This time lag may have resulted in a discrepancy between the invasive value and that estimated by DE, particularly with respect to RAP. Moreover, although the current guideline recommends the use of peak TR velocity (and not estimated systolic PAP) as the main variable for assessing the echocardiographic probability of PH, this was not mentioned in this study, and only 6% of their patients were groups 1 and 4 PH.
To avoid these limitations, we carefully screened subjects and compared the mean PAP measured invasively with the TR pressure gradient (TRPG) and systolic PAP estimated by echocardiography (sPAPECHO) by using estimated RAP according to the ASE guideline. 4) We also explored the best cutoff values of TRPG and sPAPECHO to detect the PH defined as a mean PAP !25 mmHg.
Methods
Study subjects and protocol: This study was a retrospective, cross-sectional study based on digitized data from Coronary Angiography and the Intervention Database Systems (CAIRS) at the University of Tokyo. CAIRS is a systematic database of patients undergoing cardiac catheterization and is connected to a clinical database that records background data, drug prescription data, and laboratory data (operating since January 1, 2005). 19) We obtained data on 1,172 consecutive patients who underwent elective RHC between July 2005 and December 2012. Patients who were !20 years old at the time of RHC and who underwent echocardiography with adequate images within 24 hours of RHC were included in the analysis. Echocardiography was performed in 369 patients within 24 hours of RHC, but 178 patients were excluded because TR could not be documented. Thus, we only included subjects in whom the TR envelope was clear enough to measure the TR peak velocity. Furthermore, two patients were excluded because of pulmonary stenosis. We included 189 patients with RHC and echocardiographic examinations (within 24 hours) in the final statistical analysis ( Figure  1 ). This study was approved by the institutional ethics committee of the University of Tokyo (# 2650). Right heart catheterization: The systolic, diastolic, and mean PAP were measured in all subjects during the endexpiratory period by using a 7F Swan-Ganz catheter inserted via the femoral or internal jugular vein in the catheter laboratory. All readings were referenced to the mid-axillary line with the patient in a supine position. Pressure calibration was performed before and after the pressure measurements (Figure 2 ). PAP measurements were performed during 5-10 cardiac cycles, and the mean value was calculated. Mean PAP was calculated via the integration of the pressure curve by RMC-4000 CARDIO MASTER (NIHON KOHDEN, Tokyo, Japan). Doppler echocardiography: DE was performed on the basis of current guidelines. 1, 4) The peak pressure gradient between the right ventricle and right atrium, as estimated by the modified Bernoulli equation, was calculated from the peak velocity obtained from the TR Doppler signal. The sPAPECHO was calculated as the TRPG added to the estimated RAP. The RAP was categorized into three levels (3, 8 , and 15 mmHg) on the basis of inferior vena cava diameter, together with its respiratory variation according to the current guideline of the ASE (Figure 2 ). presented are the average of three consecutive measurements. To determine the reproducibility of TR velocity measurements, a total of 10 randomly selected examinations were analyzed twice by a first investigator at a 1-week interval and once by a second investigator. The intra-and interobserver variabilities were expressed as the absolute difference between the repetitive measurements divided by their mean values. Our echocardiography equipment and laboratory are maintained under the guidelines of the Japanese Society of Echocardiography.
20)
Statistical analysis: JMP Pro version 11 was used to perform the statistical analyses. Data are expressed as mean ± standard deviation for quantitative variables with normal distribution or as median (interquartile range) for variables without normal distribution. Associations between invasive systolic PAP and DE were performed by correlation analysis. The comparison of the subjects' characteristics, echocardiographic parameters, and hemodynamic data between the groups stratified for overestimation or underestimation was performed with an unpaired t-test. BlandAltman analysis 21) was used to evaluate the agreement between the DE and systolic PAP measured by RHC. To determine the optimal cutoff values to detect PH (mean PAP !25 mmHg as measured by RHC), the receiver operating characteristic (ROC) curves for DE parameters were generated. A probability value < 0.05 was considered statistically significant.
Results

Patients' characteristics:
Invasive data and Doppler echocardiographic parameter were obtained in all patients (n = 189). Table I summarizes the characteristics of our cohort. The mean age was 58 years old, and 56% of patients were male. The indications for RHC were as follows: pulmonary arterial hypertension (24%), cardiomyopathy (24%), post-heart transplantation (20%), valvular heart disease (13%), ischemic heart disease (12%), arrhythmia (6%), and congenital heart disease (1%). Table II summarizes the hemodynamic data obtained from the RHC and DE measurements. The median value of the mean PAP was 16 (interquartile range: 12, 26) mmHg. In total, 26% of patients had PH. Association between invasive systolic PAP and sPA-PECHO: Figure 3A shows that a strong correlation existed between the systolic PAP measured by RHC and sPAPECHO (r = 0.87, P < 0.0001). However, there was a discordance of > 10 mmHg between invasive systolic PAP and sPA-PECHO in 41% of patients, and the discordance was > 20 mmHg in 9% of patients. By using Bland-Altman analysis, the positive bias for the sPAPECHO estimates of invasive systolic PAP was 6.5 mmHg with 95% limits of agreement ranging from −13.5 mmHg to 26.5 mmHg (Figure 3  B) . This finding indicates that sPAPECHO underestimated systolic PAP by as much as 13.5 mmHg and overestimated it by as much as 26.5 mmHg. Table III showed that the overestimation and underestimation of systolic PAP by DE occurred in 76% (143/189) and 23% (43/189), respectively. Among the 143 overestimate patients, 28 patients (20%) had PH, whereas 21 of the 43 underestimate patients (49%) had PH.
When limited to patients with PH only, the systolic PAP measured by RHC and sPAPECHO had good correlation (r = 0.80, P < 0.0001, Figure 3C ). However, Bland-PH ASSESSED BY THE DE METHOD Altman analysis ( Figure 3D) showed that there was a positive bias of 3.8 mmHg with wide 95% limits of agreement (−19.8 mmHg to 27.4 mmHg), thus indicating an obvious dispersion of agreement in patients with a higher systolic PAP.
Association between invasive systolic PAP and TRPG:
A strong correlation also existed between invasive systolic PAP and TRPG (r = 0.87, P < 0.0001, Figure 4A ). There was also a discordance of > 10 mmHg between invasive systolic PAP and TRPG in 28% of patients, and the discordance was > 20 mmHg in 7% of patients. Although the mean difference was small compared with sPAPECHO (−0. The correlation analysis between mean PAP and sPAPECHO showed strong association (r = 0.85, P < 0.0001). B: The ROC curve of sPAPECHO to detect PH (mean PAP ≥ 25 mmHg) showed that the optimal cutoff was 41 mmHg. C: Correlation analysis between mean PAP and TRPG also showed good association (r = 0.83, P < 0.0001). D: The ROC curve of TRPG for detecting PH (mean PAP ≥ 25 mmHg) showed that the optimal TRPG cutoff was 36 mmHg.
which were similar to those observed for sPAPECHO. Furthermore, the correlation coefficient between TRPG and invasive systolic PAP, the 95% limits of agreement, and the accuracy for detecting PH were similar to those for sPAPECHO. The mean difference between TRPG and invasive systolic PAP was small. The dispersion of agreement between TRPG and invasive systolic PAP was remarkable in patients with a higher systolic PAP ( Figures 4C, 3D ), and this finding was similar to the dispersion of agreement observed for sPAPECHO. Association among invasive mean PAP, sPAPECHO, and TRPG: Figure 4A and B show that a strong correlation existed among the mean PAP measured by RHC, sPAPECHO (r = 0.85, P < 0.0001), and TRPG (r = 0.83, P < 0.0001). Detection of PH from sPAPECHO and TRPG: For the detection of PH using sPAPECHO, ROC curve analysis showed that the optimal sPAPECHO cutoff value to detect PH was 41 mmHg, and there was very high sensitivity and specificity (0.92 and 0.91, respectively). Figure 5A and B show the association between the mean PAP measured by RHC and sPAPECHO and a representative ROC curve. Figure 5C and D show that the optimal TRPG cutoff value to detect PH was 36 mmHg and also show very high sensitivity and specificity (0.90 and 0.93, respectively) similar to the sensitivity and specificity obtained for sPAPECHO. Table IV summarizes the results of ROC curve analysis.
Observer variabilities:
The intra-and interobserver variabilities of TR velocity measurements were 2.4 ± 1.2% and 2.5 ± 1.4%, respectively.
Discussion
The key finding of this study was that the optimal sPAPECHO and TRPG cutoffs for detecting PH were 41 mmHg (sensitivity, 92%; specificity, 91%; area under the curve = 0.95) and 36 mmHg (sensitivity, 90%; specificity, 93%; area under the curve = 0.95), respectively. Furthermore, there were high sensitivity and specificity using SAWADA, ET AL either of these cutoff values.
Although it is important to attempt a more accurate estimation of systolic PAP by DE, one of the important roles of DE is to screen for suspected PH. 22) The mean PAP reflects the steady component of pulmonary flow and the functional status of the pulmonary vascular resistance, whereas the systolic PAP is expected to encompass the pulsatile component of arterial load, including the characteristics of right ventricular ejection and the characteristics of the proximal elastic pulmonary arteries and wave reflections. 2, 3, 23) Several studies 24, 25) suggested that changes in elasticity and pulsatile pressure are primarily due to an increase in mean PAP in PH. Mean PAP is a more important element in pulmonary circulation; therefore, PH is currently defined by mean PAP rather than by systolic PAP. Several reports suggested that the measurement of mean PAP is possible by DE. 26, 27) However, these methods are not as feasible as sPAPECHO and have not been widely accepted. The convention is to report systolic PAP.
We determined the optimal sPAPECHO cutoff value to detect a mean PAP !25 mmHg and found a very high sensitivity and specificity of this cutoff value to screen for PH. Although DE is not suitable for accurately estimating systolic PAP in individual patients, this result indicates that DE is a useful method for discovering suspected PH because screening is used to determine the presence or absence of PH and not necessarily the severity of the disease. RHC is needed for accurate PAP measurement and the diagnosis or management of PH; however, our results show that DE is an important screening tool for PH. Our results confirm the results of a recent large scale study 18) because both the sensitivity and specificity of sPAPECHO to detect PH were !0.79 in that study. On the contrary, we found a discrepancy between their cutoff value of 36 mmHg sPAPECHO and our cutoff value of 41 mmHg sPA-PECHO. One of the possible explanations for this result is the time lag between RHC and echocardiography (within 5 days). The prevalence of PH was also higher in their study (72%) than in our study (26%). Furthermore, there are differences in patients' characteristics between the two studies. Additional studies might be needed to determine the optimal cutoff value of sPAPECHO to screen for PH in the general population.
For TRPG, the best cutoff value for detecting PH had a similar large area under the curve compared with that of sPAPECHO in our study. This suggests that sPAPECHO had a detection accuracy that was the same as that of TRPG. Given the inaccuracies of RAP estimation using the ultrasound measurements of the inferior vena cava diameter together with its respiratory variation, [28] [29] [30] the current guideline recommends using TRPG as the main variable for assessing the echocardiographic probability of PH.
1) However, our results suggest that sPAPECHO using RAP estimation according to the current ASE guideline 4) might serve as an accurate screening for PH as TRPG. On the contrary, we found similar sensitivity and specificity in detecting the PH defined by mean PAP (Figure 5 ). Considering the simplicity of measurement, the measurement of TRPG alone may serve for screening PH in routine practice, as recommended by the ASE guideline. 4) . Our study found a good correlation between sPA-PECHO and RHC (r = 0.875, P < 0.0001), whereas the agreement between sPAPECHO and RHC showed a large variation on an individual basis. Although the correlation coefficient between sPAPECHO and RHC in this study was relatively high compared with previous reports, there was a discordance of > 10 mmHg between the estimated and measured systolic PAP in 41% of patients and a discordance of > 20 mmHg in 9% of patients. These results agree with prior studies that assessed the relationship between the sPAPECHO and systolic PAP measured by RHC. Testani, et al. 10) found that the correlation between sPA-PECHO and RHC was moderate, but the agreement was poor in a large number of patients. Other investigators demonstrated a poor correlation in patients with certain medical conditions. [31] [32] [33] Fei, et al. 33) indicated that the accuracy of the systolic PAP measured by DE was affected by severe TR and severe PH. In our study, we documented sPAP overestimation and underestimation in Table III . The potential sources of error for the assessment of systolic PAP by DE were the inaccuracies of RAP estimation by using the ultrasound measurements of the inferior vena cava diameter and the many pitfalls inherent to DE. An incomplete CW Doppler spectral envelope was the predominant cause for underestimation, whereas overestimation was due to the misinterpretation of the spectral envelope maximal velocity boundary. Robyn, et al. 34) discussed that the mild PH defined by DE might include the 1) overestimation of the sPAPECHO in a patient with true normal pulmonary pressure, 2) serendipitous observation of a rare transient pressure elevation in an otherwise healthy individual, 3) discovery of stable mild PH possibly of long duration, or 4) discovery of early progressive PH in an individual with PAH. Therefore, we need to recognize the possibility of overlooking these confounding factors whenever we estimate systolic PAP by DE. Furthermore, given that the estimation of systolic PAP by DE has some limitations, such as the effect of the "simplification" of the Bernoulli equation, vagueness of RAP estimation, inadequate Doppler angle, insufficient Doppler envelope of TR, and inadequate gain adjustment of the TR envelope, the consistent estimation of systolic PAP by DE may be difficult. Our results showed that there was a discrepancy between the DE and invasively measured PAP that was particularly apparent at a higher systolic PAP.
As recommended in the guideline, PH should not be detected solely on the basis of DE but by using additional echocardiographic variables that suggest PH (including right chamber size, blood flow velocity from the right ventricle, pulmonary artery diameter, and estimated RAP) should be assessed. 1, 4) However, according to the present study, TRPG !36 mmHg (or sPAPECHO !41 mmHg) can be one of the criteria for estimating the probability of PH, and a more extensive diagnostic workup should be performed.
Finally, one of the advantages of the present study was that the time interval between echocardiography and RHC was smaller than the previous studies. 10, 18, 33) Although we performed echocardiography within 24 hours of RHC, they were within 48 hours 10) and 5 days, 18, 33) respectively, in these previous studies. Study limitations: This study has several limitations. First, it was limited by its retrospective design and that all patients were enrolled at a single center. The study population was relatively small, and only 26% of the cohort had PH. Furthermore, the number of patients with each etiology was small. Therefore, we could not determine the etiology-specific cutoff values in each group of PH. A larger-scale study that includes patients with PH is needed to confirm our results, and the proposed cutoff values should be verified prospectively. Second, echocardiography and RHC were not performed simultaneously. Although echocardiography was performed within 24 hours of RHC and although this time lag is generally acceptable, the interpretation of TR velocity for estimating PAP was limited. This interval is shorter than that in previous studies. 10, 18, 33) Finally, there was no data on the echocardiographic assessment of the right heart, except for TR velocity and inferior vena cava diameter. Considering that we only examined the relationship between TRPG, sPA-PECHO, and invasive PAP in the present study, complete echocardiographic data were not acquired. A previous study reported that severe TR was one of the independent factors for the inaccurate estimation of systolic PAP. 33) Further investigations that combine TR and right heart echocardiographic parameters are needed.
Conclusion
The optimal sPAPECHO and TRPG cutoffs to detect PH were 41 and 36 mmHg, and both cutoffs had high sensitivity and specificity. Considering that DE is required to accurately detect PH rather than to accurately estimate systolic PAP, our results provide useful information regarding screening patients for PH and in recommending further investigations on PH. On the contrary, we need to recognize that there was a discrepancy between the measured and estimated values in individual patients.
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